Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2013 | 07-2013 | 04-2013 | 01-2013 | 10-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,068 | 32 | 410 | 920 | 2,450 |
| Receivables | 31 | 18 | 29 | 95 | 64 |
| Inventories | 430 | 365 | 781 | 836 | 864 |
| TOTAL | $1,760 | $486 | $1,330 | $1,936 | $3,458 |
| Non-Current Assets | |||||
| PPE Net | 127 | 146 | 171 | 199 | 226 |
| Intangibles | 1,399 | 1,430 | 2,004 | 1,992 | 1,988 |
| TOTAL | $1,526 | $1,576 | $2,175 | $2,191 | $2,214 |
| Total Assets | $3,286 | $2,062 | $3,505 | $4,127 | $5,672 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 771 | 1,134 | 848 | 621 | 2,094 |
| Accrued Expenses | 227 | 600 | 411 | 384 | 405 |
| Other current liabilities | 831 | 51 | 49 | 79 | 91 |
| TOTAL | $2,332 | $2,153 | $1,539 | $1,170 | $2,590 |
| Non-Current Liabilities | |||||
| Long Term Debt | 731 | 887 | 1,045 | 1,213 | N/A |
| TOTAL | $743 | $900 | $1,060 | $1,215 | $3 |
| Total Liabilities | $3,075 | $3,053 | $2,599 | $2,385 | $2,593 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,403 | 23,390 | 12,386 | 10,986 | 10,986 |
| Common Shares | 239 | 126 | 123 | 110 | 110 |
| Retained earnings | -74,015 | -70,171 | -68,012 | -66,478 | -64,654 |
| TOTAL | $211 | $-991 | $906 | $1,742 | $3,079 |
| Total Liabilities And Equity | $3,286 | $2,062 | $3,505 | $4,127 | $5,672 |